Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
this has contributed to acquiring a better physiological understanding of their metabolism in humans, while also highlighting the challenges and limitations of the current trials
It helps to unclog pores, reduce inflammation, and prevent new acne lesions from forming
[Google Scholar] Berthe-Corti L, Hulsch R, Nevries U, Eckardt-Schupp F
Chapters: 00:00 Welcome Back & Super Bowl Banter 05:50 What This Episode Covers: Growth Hormone Secretagogues 06:45 GHRH vs GHRP Explained (Simple Breakdown) 12:50 Tesamorelin: Benefits, Fat Loss & Why Its Top Tier 15:30 CJC-1295 (With vs Without DAC) 19:20 Age, Teens & Secretagogues (Who Should Not Use Them) 23:30 MK-677: Hunger, Muscle Gain & When It Makes Sense 26:50 Dosing Strategy, Timing & Cutting vs Bulking 29:00 Tesamorelin & Sleep Issues (How to Fix It) 34:30 Secretagogues vs Real HGH (What to Use & When) 38:20 Long-Term Benefits: Recovery, Aging & Fat Loss 41:20 TRT, Estrogen, AIs & Whats Coming Next 44:10 Outro & Final Thoughts We cover: GH Secretagogues 101: GHRH vs GHRP GHRH (Tesamorelin, CJC) tells the pituitary to make GH GHRP (Ipamorelin, MK-677, GHRP6) pushes the pulsing & release Why you need both sides of the equation for max effect Warehouse analogy explained: stock + shipping = full power Ranking the Peptides (Effectiveness vs Side Effects) Tesamorelin: 5/5 effectiveness, 2/5 side effects the king of fat loss & GH synergy Ipamorelin: Cleanest GHRP, low prolactin/cortisol risk CJC-1295 (no DAC): Powerful GH increase, occasional histamine response CJC w/ DAC: Long ester = higher blood levels but more estrogenic sides MK-677: Strongest hunger, fullness, and muscle but water retention & fatigue are real Hexarelin, GHRP6, GHRP2: Strong but outdated due to prolactin & side effects Side Effect Note: CJC rash/histamine reaction
However, in addition to the above biological indicators, there are still basic criteria to demonstrate the involvement of ferroptosis, which should be inhibited by lipophilic antioxidants (e.g., ferrostatin-1 and lipstatin-1)
